France

Brenus Pharma secures €11M Series A Extension to advance Cancer Immunotherapy Platform
Brenus Pharma, a Lyon-based clinical-stage biotech developing immunotherapy treatments to prevent cancer recurrence, has raised €11M in an extension of its Series A round, bringing total funding since founding to €38M.

The best Articles in our Network